Mapracorat is primarily researched for its potential anti-inflammatory and immunomodulatory properties. It is being explored as a topical treatment for various skin conditions, such as atopic dermatitis and psoriasis, due to its ability to selectively modulate glucocorticoid receptors without causing significant systemic side effects. Its targeted action makes it a promising candidate for managing localized inflammation and skin disorders, offering a safer alternative to traditional corticosteroids. Ongoing studies aim to validate its efficacy and safety in clinical settings.